CBD classed as pharmaceutical product: Taiwan regulatory report

$299.00

Contents:

1 Executive summary
2 Planting and growing
3 Extraction and manufacture
4 Importing and exporting
5 Pure CBD isolate and flower
6 Finished products
7 Regulations
8 Relevant bodies

Description

Although no longer classed as a controlled narcotic in Taiwan, CBD is currently regulated under the legal framework on pharmaceutical products following a public petition to legalise it as a prescription medicine in 2017. This report outlines all current regulations for CBD, covering extraction and manufacture, import and export and restrictions relating to finished products.

Photo: Tingyaoh

CBD-Intel does not provide legal, strategic or investment advice. Tamarind Media Limited, the publisher of CBD-Intel, does not accept any liability or responsibility for information or views published.